Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP and Chief Medical Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 232,676.059 |
Ending reported balance
After 2022-04-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-04-01 · Tax withholding · Disposed 77,960 · Balance 234,855.059 F1: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022. Row 2 · 2022-04-03 · Tax withholding · Disposed 2,179 · Balance 232,676.059 F2: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan. |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 4,805 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,805 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 53,772 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 53,772 F3: Option became exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 75,134 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 75,134 F4: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 21,894 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 21,894 F5: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 80,803 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 80,803 F6: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 84,478 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 84,478 F7: The number of shares subject to the option were calculated using a 30-day average price. F8: Options became exercisable in four equal annual installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 99,344 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 99,344 F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022.
F2: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2017 Filed Mar 22, 2017 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 16,637 | $45.07 | $749,829.59 |
DisclosureSEC source: 0001127602-17-012624 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,309.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 6,132 | $80.58 | $494,116.56 |
DisclosureSEC source: 0001127602-17-009761 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,672.059 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 16,133 | $80.58 | $1,299,997.14 |
DisclosureSEC source: 0001127602-17-009761 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,804.059 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| May 16, 2016 Filed Feb 3, 2017 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 1,930 | $104.55 | $201,781.50 |
DisclosureSEC source: 0001127602-17-003879 · form5.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,671.059 Read SEC document |
| May 05, 2016 Filed May 6, 2016 20:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 7,517 | $105.00 | $789,285.00 |
DisclosureSEC source: 0001127602-16-051401 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,601.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 53,772 | $104.82 Strike: $104.82 | $5,636,381.04 |
DisclosureSEC source: 0001127602-16-048888 · form4.xml · derivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,772 Underlying: Common Stock · 53,772 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 7,155 | $104.82 | $749,987.10 |
DisclosureSEC source: 0001127602-16-048888 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,572 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 6,924 | $104.82 | $725,773.68 |
DisclosureSEC source: 0001127602-16-048888 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,118.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| March 09, 2016 Filed Mar 11, 2016 21:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 6,755 | $100.00 | $675,500.00 |
DisclosureSEC source: 0001127602-16-046104 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,601.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 14,515 | $97.17 | $1,410,422.55 |
DisclosureSEC source: 0001127602-16-044577 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,356.059 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| October 27, 2015 Filed Oct 28, 2015 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 23,603 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-15-029685 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,604 Underlying: Common Stock · 23,603 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| October 27, 2015 Filed Oct 28, 2015 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 23,603 | $105.00 | $2,478,315.00 |
DisclosureSEC source: 0001127602-15-029685 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,841.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 27, 2015 Filed Oct 28, 2015 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 23,603 | $54.53 | $1,287,071.59 |
DisclosureSEC source: 0001127602-15-029685 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,444.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 16,637 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · derivative · entry 10 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,637 Underlying: Common Stock · 16,637 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 16,637 | $102.71 | $1,708,786.27 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 7 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,841.059 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F6 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $101.75 and $103.24 per share. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 16,637 | $45.07 | $749,829.59 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 6 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,478.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,989 | $102.71 | $409,710.19 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,841.059 F5 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 47,937 | $102.26 Strike: $102.26 | $4,902,037.62 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · derivative · entry 9 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,937 Underlying: Common Stock · 47,937 shares Expires 2022-04-01 F8 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 16,747 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · derivative · entry 8 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,747 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 6,845 | $102.26 | $699,969.70 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,858 F4 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 16,747 | $102.26 | $1,712,548.22 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,510.059 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $101.60 and $102.47 per share. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 16,747 | $34.96 | $585,475.12 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,257.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,234 | $102.26 | $228,448.84 |
DisclosureSEC source: 0001127602-15-013956 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,510.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 33,274 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-15-012425 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,274 Underlying: Common Stock · 33,274 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 33,274 | $104.94 | $3,491,773.56 |
DisclosureSEC source: 0001127602-15-012425 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,086.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $104.20 and $105.32 per share. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 33,274 | $45.07 | $1,499,659.18 |
DisclosureSEC source: 0001127602-15-012425 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,360.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 13,839 | $103.87 | $1,437,456.93 |
DisclosureSEC source: 0001127602-15-009642 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,086.059 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 50,240 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-15-000758 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,747 Underlying: Common Stock · 50,240 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 50,240 | $95.71 | $4,808,515.62 |
DisclosureSEC source: 0001127602-15-000758 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,247.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.40 and $96.85 per share. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 50,240 | $34.96 | $1,756,390.40 |
DisclosureSEC source: 0001127602-15-000758 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,487.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 54,550 | $74.29 Strike: $74.29 | $4,052,519.50 |
DisclosureSEC source: 0001127602-14-013997 · form4.xml · derivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,550 Underlying: Common Stock · 54,550 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 8,749 | $74.29 | $649,963.21 |
DisclosureSEC source: 0001127602-14-013997 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,991 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 7,166 | $74.29 | $532,362.14 |
DisclosureSEC source: 0001127602-14-013997 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,247.059 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| March 31, 2014 Filed Mar 31, 2014 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 3,456 | $75.00 | $259,200.00 |
DisclosureSEC source: 0001127602-14-012981 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,468.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 28, 2014 Filed Mar 31, 2014 20:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 15,411 | $74.18 | $1,143,187.98 |
DisclosureSEC source: 0001127602-14-012981 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,924.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 16,353 | $70.32 | $1,149,942.96 |
DisclosureSEC source: 0001127602-14-007473 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,335.059 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| November 18, 2013 Filed Nov 18, 2013 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 35,387 | $0.00 Strike: $28.26 | $0.00 |
DisclosureSEC source: 0001127602-13-031950 · form4.xml · derivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,387 shares Expires 2018-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 11/17/2011. Read SEC document |
| November 18, 2013 Filed Nov 18, 2013 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 35,387 | $65.61 | $2,321,627.83 |
DisclosureSEC source: 0001127602-13-031950 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,982.059 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 18, 2013 Filed Nov 18, 2013 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 35,387 | $28.26 | $1,000,036.62 |
DisclosureSEC source: 0001127602-13-031950 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,369.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2013 Filed Nov 18, 2013 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 15,254 | $65.62 | $1,000,967.48 |
DisclosureSEC source: 0001127602-13-031950 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,982.059 F1 · kind: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 70,773 | $0.00 Strike: $28.26 | $0.00 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · derivative · entry 11 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,387 Underlying: Common Stock · 70,773 shares Expires 2018-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 11/17/2011. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 34,423 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · derivative · entry 10 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,423 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 34,422 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · derivative · entry 9 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,423 Underlying: Common Stock · 34,422 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 70,773 | $57.34 | $4,058,123.82 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 6 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061.1502 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 70,773 | $28.26 | $2,000,044.98 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,834.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 34,423 | $57.22 | $1,969,684.06 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061.1502 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 34,423 | $36.23 | $1,247,145.29 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,484.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 34,422 | $57.34 | $1,973,757.48 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061.1502 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 34,422 | $36.23 | $1,247,109.06 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,483.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 47,207 | $54.53 Strike: $54.53 | $2,574,197.71 |
DisclosureSEC source: 0001127602-13-013269 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,207 Underlying: Common Stock · 47,207 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.